You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adagrasib

Showing 1 - 25 of 28
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors Trial (INCB099280, adagrasib)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Sep 8, 2023

Healthy Adults Trial in Daytona Beach (Adagrasib, Eltrombopag + adagrasib)

Recruiting
  • Healthy Adults
  • Adagrasib
  • Eltrombopag + adagrasib
  • Daytona Beach, Florida
    Fortrea Clinical Research Unit Daytona Beach (Labcorp Clinical R
Jun 29, 2023

Advanced Cancer, Metastatic Cancer, Malignant Tumor of Lung Trial in Santa Rosa (Adagrasib)

Recruiting
  • Advanced Cancer
  • +2 more
  • Adagrasib
  • Santa Rosa, California
    Providence Medical Foundation
May 2, 2023

Lung Cancer, Gastro-intestinal Cancer Trial in Houston (Durvalumab, Adagrasib)

Not yet recruiting
  • Lung Cancer
  • Gastro-intestinal Cancer
  • Houston, Texas
    M D Anderson Cancer Center
May 9, 2023

Solid Tumor, Adult, NSCLC, Advanced Cancer Trial (Adagrasib, nab-Sirolimus)

Not yet recruiting
  • Solid Tumor, Adult
  • +4 more
  • (no location specified)
Apr 24, 2023

Metastatic Pancreatic Cancer Trial in Houston (MRTX849)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Nov 22, 2022

Advanced Solid Tumor, NSCLCs Trial in Houston (Adagrasib, Olaparib)

Not yet recruiting
  • Advanced Solid Tumor
  • Non-small Cell Lung Cancers
  • Houston, Texas
    M D Anderson Cancer Center
Nov 15, 2023

Resectable NSCLC Trial (Adagrasib, Adagrasib/Nivolumab)

Not yet recruiting
  • Resectable Non-Small Cell Lung Cancer
  • Adagrasib
  • Adagrasib/Nivolumab
  • (no location specified)
Jul 21, 2022

Advanced NSCLC, Metastatic Lung Cancer Trial in East Syracuse, Cleveland, Bellingham (Adagrasib in combination with

Recruiting
  • Advanced NSCLC
  • Metastatic Lung Cancer
  • Adagrasib in combination with pembrolizumab
  • Pembrolizumab
  • East Syracuse, New York
  • +2 more
Nov 28, 2022

Healthy Adults Trial in Dallas (Treatment A, Treatment B)

Not yet recruiting
  • Healthy Adults
  • Treatment A
  • Treatment B
  • Dallas, Texas
    Labcorp Clinical Research Unit Inc
May 11, 2023

Non Small Cell Lung Cancer, KRAS Activating Mutation, Advanced Cancer Trial in United States (VS-6766 and adagrasib)

Recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • avutometinib (VS-6766) and adagrasib
  • San Francisco, California
  • +4 more
Dec 21, 2022

Colon Cancer, Colorectal Cancer Trial in Houston (MRTX849, Irinotecan, Cetuximab)

Not yet recruiting
  • Colon Cancer
  • Colorectal Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2023

Advanced Cancer, Metastatic Cancer, Malignant Tumor Trial in Santa Rosa (adagrasib (MRTX849))

Available
  • Advanced Cancer
  • +2 more
  • adagrasib (MRTX849)
  • Santa Rosa, California
    Providence Medical Group Santa Rosa - Cancer Center
Jan 19, 2022

NSCLC Stage IV, KRAS P.G12C Trial in Worldwide (Adagrasib)

Not yet recruiting
  • NSCLC Stage IV
  • KRAS P.G12C
  • Adagrasib
  • Brussels, Belgium
  • +26 more
Jan 3, 2023

Advanced Solid Tumors Trial in Worldwide (BMS-986466, Adagrasib, Cetuximab)

Not yet recruiting
  • Advanced Solid Tumors
  • Birmingham, Alabama
  • +24 more
Aug 29, 2023

Advanced Solid Tumor Trial in Houston, San Antonio (MRTX849, Palbociclib)

Recruiting
  • Advanced Solid Tumor
  • Houston, Texas
  • +1 more
Feb 18, 2022

Advanced Cancer, Metastatic Cancer, Malignant Tumor of Colon Trial in United States (MRTX849, BI 1701963)

Active, not recruiting
  • Advanced Cancer
  • +4 more
  • Saint Louis, Missouri
  • +3 more
Apr 4, 2022

Solid Tumor, Advanced Solid Tumor, Non Small Cell Lung Cancer Trial in Denver, Nashville, Fairfax (MRTX0902, MRTX849)

Recruiting
  • Solid Tumor
  • +3 more
  • Denver, Colorado
  • +2 more
Dec 19, 2022

Advanced Cancer, Metastatic Cancer, Malignant Neoplastic Disease Trial in United States (MRTX849, TNO155)

Active, not recruiting
  • Advanced Cancer
  • +2 more
  • Los Angeles, California
  • +11 more
Nov 12, 2021

Advanced NSCLC, Metastatic NSCLC Trial in Worldwide (MRTX849 Monotherapy, MRTX849 in Combination with Pembrolizumab)

Recruiting
  • Advanced Non-Small Cell Lung Cancer
  • Metastatic Non-Small Cell Lung Cancer
  • MRTX849 Monotherapy
  • +2 more
  • Prescott Valley, Arizona
  • +134 more
Jan 25, 2023

Metastatic Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer Trial in Worldwide (MRTX849, Docetaxel)

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Advanced Non Small Cell Lung Cancer
  • Santa Rosa, California
  • +141 more
Aug 10, 2022

Advanced Cancer, Metastatic Cancer, Malignant Neoplastic Disease Trial in Puerto Rico, United States (MRTX849, Pembrolizumab,

Recruiting
  • Advanced Cancer
  • +2 more
  • Birmingham, Alabama
  • +97 more
Jan 6, 2023

Non Small Cell Lung Cancer Metastatic, Brain Metastases, Adult, KRAS G12C Trial (JDQ443)

Not yet recruiting
  • Non Small Cell Lung Cancer Metastatic
  • +2 more
  • (no location specified)
Aug 11, 2023

Studying Pathways of Resistance in KRAS-driven Cancers

Not yet recruiting
  • KRAS P.G12C
  • FoundationOne® Liquid CDx
  • (no location specified)
Mar 9, 2022

Advanced or Metastatic Solid Tumor Trial in China (MRTX849)

Recruiting
  • Advanced or Metastatic Solid Tumor
  • Beijing, Beijing, China
  • +9 more
Jun 9, 2022